N'-[2-(1-benzyl-7-chloroindol-3-yl)-8-fluoroquinazolin-4-yl]-N-methylpropane-1,3-diamine
C27H25ClFN5 — CID 121405651
Data last refreshed: (MolForge compound catalog, from PubChem)
About N'-[2-(1-benzyl-7-chloroindol-3-yl)-8-fluoroquinazolin-4-yl]-N-methylpropane-1,3-diamine
N'-[2-(1-benzyl-7-chloroindol-3-yl)-8-fluoroquinazolin-4-yl]-N-methylpropane-1,3-diamine (PubChem CID 121405651) has the molecular formula C27H25ClFN5 and a molecular weight of 473.98 g/mol. Its IUPAC name is N'-[2-(1-benzyl-7-chloroindol-3-yl)-8-fluoroquinazolin-4-yl]-N-methylpropane-1,3-diamine.
Molecular Properties
| Compound Name | N'-[2-(1-benzyl-7-chloroindol-3-yl)-8-fluoroquinazolin-4-yl]-N-methylpropane-1,3-diamine |
|---|---|
| PubChem CID | 121405651 |
| Molecular Formula | C27H25ClFN5 |
| Molecular Weight | 473.98 g/mol |
| Exact Mass | 473.18 |
| IUPAC Name | N'-[2-(1-benzyl-7-chloroindol-3-yl)-8-fluoroquinazolin-4-yl]-N-methylpropane-1,3-diamine |
| SMILES | CNCCCNc1nc(-c2cn(Cc3ccccc3)c3c(Cl)cccc23)nc2c(F)cccc12 |
| InChI | InChI=1S/C27H25ClFN5/c1-30-14-7-15-31-26-20-11-6-13-23(29)24(20)32-27(33-26)21-17-34(16-18-8-3-2-4-9-18)25-19(21)10-5-12-22(25)28/h2-6,8-13,17,30H,7,14-16H2,1H3,(H,31,32,33) |
| InChIKey | RUWYBXSYZMSMKX-UHFFFAOYSA-N |
| XLogP | 6.11 |
| TPSA | 54.77 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 473.98 |
| LogP ≤ 5 | 6.11 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121405651 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.